Acumen Pharmaceuticals, Inc.

NASDAQ:ABOS

1.56 (USD) • At close January 14, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 33.18467.95546.9366.88694.91777.24877.999130.101157.54111.067108.764122.162135.80268.81241.40743.777-6.552
Short Term Investments 167.159192.517205.582176.636120.51767.63362.4147.50442.65478.84480.32672.07564.16200013.104
Cash and Short Term Investments 200.343260.472252.512243.522215.434144.881140.409177.605200.194189.911189.09194.237199.96468.81241.40743.7776.552
Net Receivables 00.1060.1890.225000000000.1090.1090.1090.1090
Inventory 00000000000000000
Other Current Assets 7.2896.3373.132.8683.1644.6573.6232.7242.3661.1423.0084.4244.841.6511.0040.5430
Total Current Assets 207.632266.915255.831246.615218.598149.538144.032180.329202.56191.053192.098198.661204.91370.57242.10344.4296.552
Non-Current Assets:
Property, Plant & Equipment, Net 0.3850.430.470.5030.1250.1650.2180.270.2750.280.2520.0360.0130.006000
Goodwill 00000000000000000
Intangible Assets 00.184000000000000000
Goodwill and Intangible Assets 00.184000000000000000
Long Term Investments 58.55220.90844.10862.55367.2727.31143.41915.837020.00127.65831.61929.910000
Tax Assets 0-0.184000000000000000
Other Non-Current Assets 0.4060.4760.5580.4540.3780.3910.1950.1510.4290.3440.0790.0140.0132.3650.270-6.552
Total Non-Current Assets 59.34321.99845.13663.5167.77327.86743.83216.2580.70420.62527.98931.66929.9362.3710.270-6.552
Total Assets 266.975288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4290
Liabilities & Equity:
Current Liabilities:
Account Payables 2.3424.2113.0791.3791.3622.0260.7621.642.0841.711.2191.0880.3822.9070.9180.5310
Short Term Debt 0.1290.250.2421.7320.0040.0580.1340.210.2660.2840.278000000
Tax Payables 00000000000000000
Deferred Revenue 0-0.125000000000000000
Other Current Liabilities 17.44310.9065.1519.864.7326.4477.8835.9624.2633.142.4394.0591.1071.61130.2645.8360
Total Current Liabilities 19.91415.3678.47212.9716.0988.5318.7797.8126.6135.1343.9365.1471.4894.51831.1826.3670
Non-Current Liabilities:
Long Term Debt 29.85928.08927.85127.621000000.050.124000000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 01.512.612.5600000-0.025-0.06200174.50456.65356.6530
Total Non-Current Liabilities 29.85929.59930.46130.181000000.0250.06200174.50456.65356.6530
Total Liabilities 49.77344.96638.93343.1526.0988.5318.7797.8126.6135.1593.9985.1471.489179.02287.83563.020
Equity:
Preferred Stock 000000000000000017.4
Common Stock 0.0060.0060.0060.0060.0060.0040.0040.0040.0040.0040.0040.0040.0040000
Retained Earnings -287.973-258.208-237.671-222.798-206.301-193.344-181.734-170.427-157.561-146.851-136.7-127.571-119.222-115.32-53.962-26.9650
Accumulated Other Comprehensive Income/Loss 0.518-0.164-0.1440.312-0.509-0.646-0.524-0.751-0.965-0.965-0.814-0.231-0.028000-11.42
Other Total Stockholders Equity 504.651502.313499.843489.453487.077362.86361.339359.949355.173354.331353.599352.981352.6069.24165.1538.3740
Total Shareholders Equity 217.202243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089225.183233.36-106.079-45.462-18.5915.98
Total Equity 217.202243.947262.034266.973280.273168.874179.085188.775196.651206.519216.089000005.98
Total Liabilities & Shareholders Equity 266.975288.913300.967310.125286.371177.405187.864196.587203.264211.678220.087230.33234.84972.94342.37344.4295.98